VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 234 filers reported holding VERACYTE INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,717,755 | +0.6% | 3,211,630 | +14.8% | 0.02% | +4.3% |
| Q2 2023 | $71,278,287 | +39.2% | 2,798,465 | +21.9% | 0.02% | +35.3% |
| Q1 2023 | $51,199,187 | +163637.8% | 2,296,135 | +74.3% | 0.02% | +88.9% |
| Q4 2022 | $31,269 | -99.8% | 1,317,648 | +63.3% | 0.01% | +80.0% |
| Q3 2022 | $13,397,000 | +1413.8% | 807,066 | +1717.1% | 0.01% | – |
| Q2 2022 | $885,000 | +186.4% | 44,415 | +296.5% | 0.00% | – |
| Q1 2022 | $309,000 | -34.1% | 11,202 | -1.5% | 0.00% | – |
| Q4 2021 | $469,000 | -73.6% | 11,377 | -70.3% | 0.00% | -100.0% |
| Q3 2021 | $1,778,000 | -32.2% | 38,274 | -41.6% | 0.00% | 0.0% |
| Q2 2021 | $2,621,000 | -79.4% | 65,531 | -72.3% | 0.00% | -75.0% |
| Q1 2021 | $12,728,000 | +151.2% | 236,994 | +129.0% | 0.00% | +100.0% |
| Q4 2020 | $5,066,000 | +395.2% | 103,471 | +228.8% | 0.00% | – |
| Q3 2020 | $1,023,000 | – | 31,472 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 119,680 | $2,672 | 2.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 239,571 | $5,349,620 | 1.62% |
| OBERWEIS ASSET MANAGEMENT INC/ | 597,540 | $13,343,068 | 1.42% |
| ARK Investment Management | 7,593,592 | $169,564,898 | 1.30% |
| Capital Impact Advisors, LLC | 32,969 | $736,198 | 1.23% |
| EFG Asset Management (North America) Corp. | 229,837 | $5,127,663 | 1.22% |
| Parkman Healthcare Partners LLC | 225,872 | $5,043,722 | 0.92% |
| Nikko Asset Management Americas, Inc. | 3,173,576 | $70,770,745 | 0.85% |
| Granite Investment Partners, LLC | 865,770 | $19,332,644 | 0.81% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 175,749 | $3,924,475 | 0.64% |